Lexicon Pharmaceuticals (LXRX) Inventory Average (2017 - 2026)
Lexicon Pharmaceuticals (LXRX) reported Inventory Average of $278500.0 for Q1 2026, up 28.94% year-over-year from $216000.0 in Q1 2025, and up 26.88% on a QoQ basis from $219500.0 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) has 8 years of Inventory Average data on file, last reported at $278500.0 in Q1 2026.
- Quarterly Inventory Average rose 28.94% year-over-year to $278500.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $278500.0 (up 28.94% YoY) and the FY2025 annual result came in at $256000.0, down 16.34% from the prior year.
- Inventory Average improved to $278500.0 in Q1 2026 per LXRX's latest filing, from $219500.0 in the prior quarter.
- Across five years, Inventory Average topped out at $610500.0 in Q3 2024 and bottomed at $163000.0 in Q3 2025.
- The 4-year median for Inventory Average is $278500.0 (2026), against an average of $337727.3.
- The widest annual swing landed in 2024, when Inventory Average soared 140.35%; it then tumbled 73.3% in 2025.
- Tracing LXRX's Inventory Average over 4 years: stood at $358500.0 in 2023, then increased by 20.92% to $433500.0 in 2024, then slumped by 49.37% to $219500.0 in 2025, then gained by 26.88% to $278500.0 in 2026.
- Per Business Quant, the three latest LXRX Inventory Average figures stand at $278500.0 (Q1 2026), $219500.0 (Q4 2025), and $163000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Lexicon Pharmaceuticals | 872.52 Mn | 701.87 Mn | 20.99 Mn | 278,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 278,500.00 |
| Dec 31, 2025 | 219,500.00 |
| Sep 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 184,500.00 |
| Mar 31, 2025 | 216,000.00 |
| Dec 31, 2024 | 433,500.00 |
| Sep 30, 2024 | 610,500.00 |
| Jun 30, 2024 | 549,500.00 |
| Mar 31, 2024 | 447,500.00 |
| Dec 31, 2023 | 358,500.00 |
| Sep 30, 2023 | 254,000.00 |
| Jun 30, 2020 | 4.07 Mn |
| Mar 31, 2020 | 4.20 Mn |
| Dec 31, 2019 | 4.36 Mn |
| Sep 30, 2019 | 4.38 Mn |
| Jun 30, 2019 | 4.44 Mn |
| Mar 31, 2019 | 4.64 Mn |
| Dec 31, 2018 | 4.72 Mn |
| Sep 30, 2018 | 3.45 Mn |
| Jun 30, 2018 | 2.13 Mn |
| Mar 31, 2018 | 2.03 Mn |
| Dec 31, 2017 | 2.05 Mn |
| Sep 30, 2017 | 1.48 Mn |
| Jun 30, 2017 | 523,500.00 |